METTL14 and retinopathy of prematurity: In conclusion, our study reveals that METTL14 in microglia promotes pathological retinal neovascularization through binding with MXD1 mRNA in a YTHDF2-dependent manner, offering new therapeutic strategies and potential targets for RNV diseases including ROP.